Biofrontera Inc. (BFRI)
NASDAQ
Real-time Data
01:30 PM
Day's Range
0.898352 wk Range
0.5550Overview - BFRI - Biofrontera Inc.
Key Statistics
Valuation
Enterprise Value
17.91M
P/E (Trailing)
‪0.88‬
P/E (Forward)
‪2.12‬
PEG Ratio
‪-0.0097‬
Price / Sales (TTM)
‪0.29‬
Price / Book
‪2.17‬
EV / EBITDA
‪-3.00‬
Profitability
Gross Margin
‪79.92%‬
Profit Margin
‪-13.78%‬
Operating Margin
‪-4.36%‬
Return on Assets
‪-17.45%‬
Return on Equity
‪-988.35%‬
Ownership
Shares Outstanding
14.20M
Float
11.81M
Short % of Shares Outstanding
‪3.24%‬
Held by Insiders
‪11.99%‬
Held by Institutions
‪20.71%‬
Price stats
Beta
‪0.87‬
50-Day Avg
‪1.31‬
200-Day Avg
‪1.02‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
2 analysts
Average price target
‪$ 6.00‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BFRI - Biofrontera Inc.
Peers - BFRI - Biofrontera Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on NASDAQ.
- BFRINASDAQBiofrontera Inc.13.23MMarket Cap-18.97%52-week change0.89P/E (Trailing)‪-13.78%‬Profit Margin
- NBIXNASDAQNeurocrine Biosciences, Inc.14.55BMarket Cap+2.62%52-week change20.93P/E (Trailing)‪20.91%‬Profit Margin
- AMRXNASDAQAmneal Pharmaceuticals, Inc.7.07BMarket Cap+48.03%52-week change42.29P/E (Trailing)‪5.04%‬Profit Margin
- ALKSNASDAQAlkermes plc7.00BMarket Cap+25.77%52-week change109.87P/E (Trailing)‪3.96%‬Profit Margin
- LNTHNASDAQLantheus Holdings Inc.6.52BMarket Cap+47.28%52-week change23.91P/E (Trailing)‪17.69%‬Profit Margin
- KNSANASDAQKiniksa Pharmaceuticals International, plc Class A Ordinary Shares5.83BMarket Cap+49.48%52-week change76.56P/E (Trailing)‪9.59%‬Profit Margin
- DIODNASDAQDiodes Incorporated4.43BMarket Cap+49.74%52-week change57.61P/E (Trailing)‪5.26%‬Profit Margin
Profile Summary - BFRI - Biofrontera Inc.
About
Biofrontera Inc. is a U.S.-based biopharmaceutical company focused on dermatology products with an emphasis on photodynamic therapy. Its commercial portfolio centers on Ameluz, a prescription topical gel used together with BF-RhodoLED and RhodoLED lamp systems for the treatment of actinic keratoses, a common…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
